Nurix Therapeutics (NRIX)
(Delayed Data from NSDQ)
$11.04 USD
-0.22 (-1.95%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $11.02 -0.02 (-0.18%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Nurix Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
NRIX 11.04 -0.22(-1.95%)
Will NRIX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NRIX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NRIX
Nurix Therapeutics, Inc. (NRIX) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Wall Street Analysts Predict a 143.41% Upside in Nurix Therapeutics (NRIX): Here's What You Should Know
NRIX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Immunome (IMNM) Soars 6.0%: Is Further Upside Left in the Stock?
Beyond Air, Inc. (XAIR) Reports Q4 Loss, Misses Revenue Estimates
Nurix Therapeutics (NRIX) Moves 14.2% Higher: Will This Strength Last?
Other News for NRIX
Insider Sell Alert: Houte Van Sells Shares of Nurix Therapeutics Inc (NRIX)
Oppenheimer Reiterates Outperform Rating for Nurix Therapeutics (NRIX) | NRIX Stock News
Oppenheimer Adjusts Price Target for Nurix Therapeutics (NRIX)
Nurix Therapeutics price target lowered by $2 at Oppenheimer, here's why
6 Analysts Assess Nurix Therapeutics: What You Need To Know